Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods
NCT02657694
·
clinicaltrials.gov ↗
UNKNOWN
Status
10000
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
Sofosbuvir+Ledipasvir
DRUG:
Sofosbuvir+Daclatasvir
DRUG:
Sofosbuvir+Velpatasvir
Sponsor
FixHepC